Product Information
ROSUVASTATIN CALCIUM 5 MG TAB is a generic product labeled by Biocon Pharma Inc., priced at $0.0321 per EA under NDC 70377000613. Its NADAC has been published 397 times since Feb 27, 2019.
FDA first approved this application on Oct 31, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5 mg/1
Manufacturer
Biocon Pharma Inc.NDC
70377000613
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ROSUVASTATIN CALCIUMApproval Type
Generic (ANDA)
FDA Application
ANDA207752FDA Approved
10/31/2016
TE Code
AB
On Market Since
10/31/2016
Pharmacological Classes
Price Statistics
The NADAC for ROSUVASTATIN CALCIUM 5 MG TAB has been published 397 times since Feb 27, 2019, and over the history we have for it it has declined 69.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0321 per EA |
|---|---|
| All-time high | $0.1066 (Mar 13, 2019) |
| All-time low | $0.0321 (Sep 23, 2026) |
| 52-week high | $0.0385 |
| 52-week low | $0.0321 |
| Median price | $0.0529 |
| Average price | $0.0608 |
| Largest weekly change | -22.3% (Dec 20, 2023) |
| Weeks tracked | 397 |
| Tracking since | Feb 27, 2019 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Biocon Pharma Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Rosuvastatin calcium market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
HMG-CoA Reductase Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ROSUVASTATIN CALCIUM 5 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for ROSUVASTATIN CALCIUM 5 MG TAB, manufactured by Biocon Pharma Inc., is $0.0321 per EA (NDC 70377000613), effective Sep 30, 2026.
How has the price of ROSUVASTATIN CALCIUM 5 MG TAB changed over time?
Over the history we have for it, the NADAC for ROSUVASTATIN CALCIUM 5 MG TAB has declined 69.8%. It has been tracked across 397 weekly CMS publications since Feb 27, 2019.
What are the highest and lowest recorded NADAC prices for ROSUVASTATIN CALCIUM 5 MG TAB?
Since Feb 27, 2019, the NADAC for ROSUVASTATIN CALCIUM 5 MG TAB has ranged from a low of $0.0321 (Sep 23, 2026) to a high of $0.1066 (Mar 13, 2019), with a median of $0.0529 per EA.
Are there cheaper alternatives to ROSUVASTATIN CALCIUM 5 MG TAB?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as ROSUVASTATIN CALCIUM 5 MG TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures ROSUVASTATIN CALCIUM 5 MG TAB?
ROSUVASTATIN CALCIUM 5 MG TAB (NDC 70377000613) is labeled by Biocon Pharma Inc., and CMS classifies it as a generic product.